Chronic cough and frequent lung infections? AffloVest can help.
*AffloVest is distributed in the U.S.
AffloVest is the lightest, first truly portable High Frequency Chest Wall Oscillation (HFCWO) vest, now available in the U.S. Approved for Medicare and private health insurance reimbursement, AffloVest provides treatment of respiratory diseases like Chronic Obstructive Pulmonary Disease (COPD), Cystic Fibrosis, Chronic Bronchitis, and similar related ailments. Unlike other HFCWO vests, the AffloVe
st features built-in oscillating compressor modules that allow for freedom of movement to travel, go for a walk in the park, move around the house, or relax in front of the television. The AffloVest is a physician prescribed oscillation treatment device. Respiratory patients should consult their physician to determine how AffloVest can help.
04/17/2026
Chronic cough? Frequent lung infections?
Bronchiectasis often looks like COPD but may not respond to COPD therapy.
If you’ve been dealing with ongoing symptoms, it may be worth talking to your physician.
Managing cystic fibrosis requires a multidisciplinary approach, and Airway Clearance Therapy is a cornerstone of care.
AffloVest delivers clinically-supported HFCWO therapy in a mobile form, making it easier for patients to stay adherent without interrupting daily life.
In a blinded, independent study, 93% of participants preferred AffloVest across multiple categories: comfort, lifestyle fit, and likelihood of daily use.
When therapy is easier to tolerate and fits into a patient’s life, adherence improves—and so do outcomes.
Bronchiectasis is more than mucus buildup, it’s a progressive cascade of inflammation, infection, and structural airway damage. Known as the Vicious Vortex, this clinical model emphasizes the importance of early intervention and proactive management.
Chronic mucus retention contributes to inflammation, infection, and long-term damage in diseases like bronchiectasis and cystic fibrosis. Airway clearance therapy (ACT) is essential to manage these conditions, but adherence is important.
That’s where AffloVest makes a difference. It's mobile, comfortable, and battery-powered -- and it removes the barriers many patients face with traditional HFCWO therapy.
Join us March 18 for a live continuing education webinar: Myopathy: a Scientific Review.
Dr. Stuart Inglis, PhD will review the causes of myopathy, explain how muscle physiology changes in disease states, and discuss how these changes can contribute to weakness, fatigue, and breathing challenges.
This complimentary 1-hour webinar offers:
• 1.0 CRCE credit (AARC approved)
• 1 CBRN contact hour for nurses
Be the first to know and let us send you an email when AffloVest posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.
AffloVest is the lightest, first truly portable during use High Frequency Chest Wall Oscillation (HFCWO) vest, available in the U.S. Approved for Medicare and private health insurance reimbursement, AffloVest provides Airway Clearance Therapy for respiratory diseases like Chronic Obstructive Pulmonary Disease (COPD)/Bronchiectasis, Cystic Fibrosis, Neuromuscular Diseases, and similar related ailments.
Unlike other HFCWO vests, the AffloVest features Direct Dynamic Oscillation technology that provides Mobile CPT and allows for freedom of movement during use to travel, go for a walk in the park, move around the house, or relax in front of the television.
The AffloVest is a physician prescribed HFCWO device. Respiratory patients should consult their physician to determine how AffloVest can help.